Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
European Archives of Psychiatry and Clinical Neuroscience|January 30, 2023
mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical developmentShigeyuki Chaki, Mai Watanabe
Current Pharmaceutical Design|March 2, 2011
Targeting of metabotropic glutamate receptors for the treatment of schizophreniaShigeyuki Chaki, Hirohiko Hikichi
International Journal of Molecular Sciences|March 16, 2019
Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to KetamineShigeyuki Chaki, Kenichi Fukumoto
Current Topics in Medicinal Chemistry|June 23, 2007
Melanocortin-4 receptor antagonists for the treatment of depression and anxiety disordersShigeyuki Chaki, Taketoshi Okubo
Journal of Experimental Neuroscience|December 22, 2018
Is the History Repeated? Can (2R,6R)-Hydroxynorketamine be Another Antidepressant?Shigeyuki Chaki, Jun-Ichi Yamaguchi
Recent Patents on CNS Drug Discovery|January 29, 2008
Non-monoamine-based approach for the treatment of depression and anxiety disordersShigeyuki Chaki, Taketoshi Okubo, Yoshinori Sekiguchi
Neuroscience Letters|June 20, 2006
Group II metabotropic glutamate receptor-mediated regulation of dopamine release from slices of rat nucleus accumbensShigeyuki Chaki, Ryoko Yoshikawa, Shigeru Okuyama
Pageof 14